2025 annual financial data
Niagen Bioscience 2025 Net margin
Direct answer
Net margin was 13.43%.
Operating income was 14,296,000 USD and net income was 17,382,000 USD.
Operating cash flow was 13,437,000 USD.
Get free Niagen Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 129,423,000 USD
- Operating income
- 14,296,000 USD
- Net income
- 17,382,000 USD
- Operating cash flow
- 13,437,000 USD